Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24)

The summary for the Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention ERA, which is the U.S. government agency offering this grant.

Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24): The National Mesothelioma Virtual Bank for Translational Research (NMVB) was established in fiscal year 2006 to serve as an exceptional resource for mesothelioma research. RFA-OH-21-007 will continue the NMVB to advance biomedical research for malignant mesothelioma to gain a better understanding of the disease and its progression, and the potential development of new treatments, therapeutics, and diagnostics for mesothelioma. Continued support to the NMVB will allow expansion of collection of biospecimens, related data, and other information. NIOSH intends to continue the NMVB at the University of Pittsburgh to accomplish the following important program priorities: maintain uninterrupted assistance to mesothelioma researchers; avoid critical support gaps for current or pending mesothelioma research efforts; demonstrate a sustained public health commitment to advancing the treatment of mesothelioma; and affirm a sustained commitment to workers and other people impacted by this disease.